Skip to main content

NASDAQ:TRIL Stock Forecast, Price Targets (Buy or Sell) | TRIL Trillium Therapeutics Inc. Analyst Ratings



Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period.

We estimate TRIL Trillium Therapeutics Inc. stock forecast parameters by: Crystal Oscillators with Sign Test



TRIL Trillium Therapeutics Inc. Stock Forecast (Buy or Sell) as of 21 Apr 2022 for (n+3m)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Crystal Oscillators and Sign Test. Machine Learning based stock forecast (n+3m) for TRIL Trillium Therapeutics Inc. as below:

Time series to forecast n: 21 Apr 2022 for (n+3m)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |